A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression

Гидрогель, чувствительный к активным формам кислорода и содержащий нанопереносчики siRNA матриксной металлопротеиназы-13, для замедления прогрессирования остеоартрита
Xiaolian Sun, Peng Wang, Jing Jin, Qing Yan Jiang, Qiuyang Wang, Kai Feng, Guangsheng Wan, Wei Ming Liao, Weijun Wang
2025-01-15

Fe3O4 nanocarriersIntra-articular injectionMMP-13 siRNAOsteoarthritisROS-responsive hydrogel
RNA interference (RNAi) and oxidative stress inhibition therapeutic strategies have been extensively utilized in the treatment of osteoarthritis (OA), the most prevalent degenerative joint disease. However, the synergistic effects of these approaches on attenuating OA progression remain largely unexplored. In this study, matrix metalloproteinase-13 siRNA (siMMP-13) was incorporated onto polyethylenimine (PEI)-polyethylene glycol (PEG) modified Fe3O4 nanoparticles, forming a nucleic acid nanocarrier termed si-Fe NPs. Subsequently, a poly(vinyl alcohol) (PVA) crosslinked phenylboronic acid (PBA)-modified hyaluronic acid (HA) hydrogel (HPP) was used to encapsulate the si-Fe NPs, resulting in a bifunctional hydrogel (si-Fe-HPP) with reactive oxygen species (ROS)-responsive and RNAi therapeutic properties. Studies in vitro demonstrated that si-Fe-HPP exhibited excellent biocompatibility, anti-inflammatory effects and prolonged stable retention time in knee joint. Intra-articular injection of si-Fe-HPP significantly attenuated cartilage degradation in mice with destabilization of the medial meniscus (DMM)-induced OA. The si-Fe-HPP treatment not only notably alleviated synovitis, osteophyte formation and subchondral bone sclerosis, but also markedly improved physical activity and reduced pain in DMM-induced OA mice. This study reveals that si-Fe-HPP, with its ROS-responsive and RNAi abilities, can significantly protect chondrocytes and attenuate OA progression, providing novel insights and directions for the development of therapeutic materials for OA treatment.
1
A bifunctional si-Fe-HPP hydrogel was developed by encapsulating MMP-13 siRNA-loaded PEI-PEG-modified Fe3O4 nanoparticles in a ROS-responsive PBA-modified hyaluronic acid hydrogel.
2
In vitro, si-Fe-HPP showed excellent biocompatibility, anti-inflammatory activity, and prolonged stable retention in the knee joint.
3
Intra-articular si-Fe-HPP significantly reduced cartilage degradation, synovitis, osteophyte formation, and subchondral bone sclerosis in DMM-induced osteoarthritis mice.
4
The hydrogel combines ROS-responsive oxidative-stress modulation with RNA interference targeting MMP-13 to protect cartilage in osteoarthritis.
5
Treatment improved physical activity and reduced pain in osteoarthritis mice, supporting si-Fe-HPP as a potential therapeutic biomaterial.

ROS-responsive si-Fe-HPP bifunctional hydrogel for intra-articular treatment of DMM-induced osteoarthritis in mice

The synergistic therapeutic effects of ROS inhibition and MMP-13 RNA interference on cartilage degradation, synovitis, osteophyte formation, subchondral bone sclerosis, physical activity, and pain during osteoarthritis progression

Publication Details
Publication Date
2025-01-15
Journal
Publisher
ISSN
Cited by
54
Access Type
Author Information
Authors
Xiaolian Sun
Peng Wang
Jing Jin
Qing Yan Jiang
Qiuyang Wang
Kai Feng
Guangsheng Wan
Wei Ming Liao
Weijun Wang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%